DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
B•••••• O•••• L••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $25.9M
sum of BDC pieces, a lower bound
Fair value
$25.9M
100c on cost, debt pieces
Unfunded
$1.6M
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
3
0 equity pieces beside them
Next maturity
May 31, 2027
$25.9M inside 24 months
On the tape since
Jun 30, 2023
latest Jun 30, 2026
Events
13
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $18.9M | 100c | S+725 bp | May 31, 2027 | 1 |
| second lien term loan second lien | at least $7.0M | 100c | S+1000 bp PIK 100.00% | May 31, 2027 | 1 |
| second lien revolver second lien | unknown | n/a | unstated | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| C•••••• S•••••• L••••••• I••• | term loan second lien Investment | N••••••••• I••••• | S••••• L••• D••• | $7.0M | $7.0M 100c | S+1000 bp PIK 100.00% |
| C•••••• S•••••• L••••••• I••• | term loan first lien Investment | N••••••••• I••••• | F•••• L••• D••• | H••••••••• & P••••••••• 1 | $351,000 | $351,000 100c | S+700 bp |
| C•••••• S•••••• L••••••• I••• | term loan first lien Investment | N••••••••• I••••• | F•••• L••• D••• | H••••••••• & P••••••••• 2 | $4.8M | $4.8M 100c | S+725 bp |
| C•••••• S•••••• L••••••• I••• | revolver second lien Investments | N••••••••• | F•••• and S••••• L••• D••• | R••••••• | n/a | n/a | |
| C•••••• S•••••• L••••••• I••• | term loan first lien Investment | N••••••••• I••••• | F•••• L••• D••• | H••••••••• & P••••••••• 3 | $13.7M | $13.7M 100c | S+725 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $25.9M | $25.9M | 100c | 1 |
| Mar 31, 2026 | 1 | $25.7M | $25.7M | 100c | 1 |
| Dec 31, 2025 | 1 | $25.1M | $25.1M | 101c | 1 |
| Sep 30, 2025 | 1 | $25.0M | $25.0M | 101c | 1 |
| Jun 30, 2025 | 1 | $24.8M | $24.8M | 101c | 1 |
| Mar 31, 2025 | 1 | $24.6M | $24.6M | 102c | 1 |
| Dec 31, 2024 | 1 | $73.3M | $73.3M | 102c | 3 |
| Sep 30, 2024 | 1 | $24.3M | $24.3M | 103c | 1 |
| Jun 30, 2024 | 1 | $24.1M | $24.1M | 103c | 1 |
| Mar 31, 2024 | 1 | $23.8M | $22.7M | 101c | 4 |
| Dec 31, 2023 | 1 | $23.2M | $21.4M | 97c | 4 |
| Sep 30, 2023 | 1 | $22.8M | $20.8M | 95c | 4 |
| Jun 30, 2023 | 1 | $17.8M | $17.8M | 100c | 3 |
What changed
- Maturity approachingMay 31, 2027
- Maturity approachingMay 31, 2027
- Maturity approachingMay 31, 2027
- Maturity approachingMay 31, 2027
- Maturity approachingMay 31, 2027
- Maturity approachingMay 31, 2027
- Maturity extended (observed)Jun 30, 2026
- Maturity extended (observed)Jun 30, 2026
- Maturity extended (observed)Jun 30, 2026
- Maturity extended (observed)Jun 30, 2026
- Mark recoveredMar 31, 2024
- Mark recoveredDec 31, 2023
- PIK interest increasedSep 30, 2023
- Spread changed (observed)Sep 30, 2023
- PIK interest increasedSep 30, 2023
- Spread increasedSep 30, 2023
- New borrower on a BDC scheduleJun 30, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- B•••••• O•••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it